we treated 17 patients who had moderate to severe alzheimer 's disease with oral tetrahydroaminoacridine ( tha ) , a centrally active anticholinesterase , in a three-phase study .
C0002395
alzheimer 's disease
C0039245
tetrahydroaminoacridine